Brief: Adverum Biotechnologies Presents Anatomical Improvements In Intraretinal And Subretinal Fluid After A Single IVT Injection Of IXO-VEC
30/09/2022 21:51
Sept 30 (Reuters) - Adverum Biotechnologies Inc
ADVM.O :
* ADVERUM BIOTECHNOLOGIES PRESENTS ANATOMICAL IMPROVEMENTS
IN
INTRARETINAL AND SUBRETINAL FLUID AFTER A SINGLE IVT INJECTION
OF IXO-VEC (ADVM-022) IN THE OPTIC STUDY IN WET AMD
Source text for Eikon: ID:nGNX6wX6Jh
Further company coverage: ADVM.O
Recent news on Adverum Biotechnologies
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Adverum Reminds Stockholders To Tender Their Shares Into The Offer By Lilly
Brief: Adverum Biotechnologies Inc - Are-Nc Region No. 21 Llc Terminates Certain Lease Agreement With Adverum Biotechnologies - SEC Filing
Eli Lilly bets on eye care with buyout of gene therapy developer Adverum (updated)